Search results for "Hydroxyethyl starch"

showing 10 items of 29 documents

Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings.

2003

Objective: The perioperative use of colloidal plasma substitutes is still under discussion. We therefore conducted a prospective randomised study with three commonly used plasma substitutes to examine their histamine releasing effects in 21 volunteers. Material or subjects: 21 male volunteers were enrolled in this prospective, randomised, controlled clinical study. Endpoints were the incidence of early and late histamine release and the time course of the release kinetics. Normovolemic hemodilution technique was used with hydroxyethyl starch (n = 6), human albumin (n = 6) and polygeline (n = 9). Measurement and observation period was 240 min after the start of the plasma substitute infusion…

AdultMaleSide effectImmunologyPlasma SubstitutesBlood PressureHydroxyethyl starchPlasma SubstitutesHistamine ReleaseHydroxyethyl Starch Derivativeschemistry.chemical_compoundDouble-Blind MethodHeart RateIntensive carePolygelinemedicineHumansSerum AlbuminHetastarchAgedPharmacologyHemodilutionChemistryAlbuminHemodynamicsMiddle AgedAnesthesiaPolygelineHistaminemedicine.drugHistamineInflammation research : official journal of the European Histamine Research Society ... [et al.]
researchProduct

Macroamylasaemia after treatment with hydroxyethyl starch

1977

After infusion of 500 ml of 6% hydroxyethyl starch into fifty-four patients an increase of serum amylase was observed which in fifty-one cases exceeded the upper limit of normal (190 U/l). In most cases serum amylase reached twice the basal value. Renal function influenced the duration of the increase in serum amylase, but not the maximum increase (201+/-15 U/l; mean+/-SEM). In patients with advanced renal failure (glomerular filtration rate (GFR) = 2-10 ml/min) serum amylase was still markedly elevated after 72 h (298+/-24 U/l; mean+/-SEM). In patients with normal renal function (GFR greater than 90 ml/min) serum amylase decreased to 183+/-40 U/l (mean+/-SEM) within 72 h without reaching b…

AdultMalemedicine.medical_specialtyPancreatic diseaseClinical BiochemistryRenal functionUrineIn Vitro TechniquesHydroxyethyl starchBiochemistryHydroxyethyl Starch DerivativesExcretionBasal (phylogenetics)Renal DialysisInternal medicinemedicineHumansInfusions ParenteralAmylaseLipasePancreasbiologyChemistryStarchGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyAmylasesHypertensionChromatography Gelbiology.proteinKidney Failure ChronicFemaleGlomerular Filtration Ratemedicine.drugEuropean Journal of Clinical Investigation
researchProduct

[Treatment of sensorineural hearing loss in acute viral otitis media with intratympanic dexamethasone and hyaluronic acid in comparison with intraven…

2006

Background: Intratympanic dexamethasone with hyaluronic acid has shown to be an effective treatment of the inner ear damage in sudden hearing loss and Meniere's disease. It is not known yet if the same applies to the toxic inner ear damage in acute viral otitis media. Patients: Retrospectively, 26 patients who suffered from acute viral otitis media with sensorineural hearing loss were examined with regard to the improvement of their inner ear hearing loss. Twelve patients were treated with intravenous therapy only, consisting of hydroxyethylstarch, pentoxifylline and prednisolone. Fourteen patients additionally received intratympanic injections, consisting of dexamethasone and hyaluronic ac…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentHearing Loss SensorineuralPrednisoloneVasodilator AgentsAnti-Inflammatory AgentsEar MiddleDexamethasonePentoxifyllineInjectionsHydroxyethyl Starch DerivativesAdjuvants ImmunologicAudiometryotorhinolaryngologic diseasesmedicineHumansHyaluronic AcidPentoxifyllineInfusions IntravenousDexamethasoneRetrospective StudiesRound windowmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseSurgeryOtitis MediaOtitismedicine.anatomical_structureOtorhinolaryngologyIntravenous therapyAnesthesiaData Interpretation StatisticalAcute DiseasePrednisoloneSensorineural hearing lossDrug Therapy CombinationFemalesense organsmedicine.symptomAudiometrybusinessBone Conductionmedicine.drugLaryngo- rhino- otologie
researchProduct

Multivalency Beats Complexity: A Study on the Cell Uptake of Carbohydrate Functionalized Nanocarriers to Dendritic Cells.

2020

Herein, we report the synthesis of carbohydrate and glycodendron structures for dendritic cell targeting, which were subsequently bound to hydroxyethyl starch (HES) nanocapsules prepared by the inverse miniemulsion technique. The uptake of the carbohydrate-functionalized HES nanocapsules into immature human dendritic cells (hDCs) revealed a strong dependence on the used carbohydrate. A multivalent mannose-terminated dendron was found to be far superior in uptake compared to the structurally more complex oligosaccharides used.

CellcarbohydratesBlood DonorsHydroxyethyl starch010402 general chemistryLigands01 natural sciencesNanocapsulesArticleHydroxyethyl Starch DerivativesDrug Delivery SystemsDendrimermedicineHumanslcsh:QH301-705.5Cells Cultured010405 organic chemistryChemistrynanocapsulesBiological TransportGeneral MedicineDendritic cellDendritic CellsCarbohydrate0104 chemical sciencesMiniemulsionmedicine.anatomical_structurelcsh:Biology (General)BiophysicsglycodendronsNanocarrierscell targetingmedicine.drugCells
researchProduct

Die Elimination von Hydroxyäthylstärke 200/0,5, Dextran 40 und Oxypolygelatine

1982

After withdrawal of 400 ml whole blood and subsequent infusion of 500 ml of a colloidal plasma substituent, the intravascular and renal colloid elimination was investigated in 40 test subjects. The individual colloidal solutions could no longer be demonstrated in the intravascular space after the following times: 10% hydroxyethyl starch 200/0.5 (anthrone method) after six weeks, 10% dextran 40 (anthrone method) after two weeks, 6% hydroxyethyl starch 200/0.5 (anthrone method) after four weeks and 5.5% oxypolygelatine (hydroxyproline method) after two days. Colloidal plasma substitutes are polydisperse solutions with various molecular weights and degree of hydroxyethylation and therefore, al…

ChromatographyMolecular massChemistryHalf-lifeGeneral MedicineHydroxyethyl starchAnthronePlasma Substituteschemistry.chemical_compoundHydroxyprolineColloidDrug DiscoverymedicineMolecular MedicineGenetics (clinical)Whole bloodmedicine.drugKlinische Wochenschrift
researchProduct

Retarded Elimination of a High-Molecular Enzyme-Substrate-Complex after Hydroxyethyl-Starch-Infusion

1978

During a pharmacokinetic study with hydroxyethyl starch we found, that this plasma substitute induces a regular increase of serum amylase. In 54 patients after infusion of 500 ml 6% hydroxyethyl starch (HES) an increase of serum amylase was observed, which in 51 cases exceeded the upper limit of normal (190 U/l). In most cases serum amylase reached values twice as high as the basal value. Renal function influenced duration of increased serum amylase values, but did not influence maximum increases (201 ±15 U/l; mean ± SEM). In patients with advanced renal failure (GFR = 2–10 ml/min) serum amylase was still markedly elevated after 72 hours (298 ± U/l; mean ± SEM). In patients with normal rena…

Enzyme substrate complexmedicine.medical_specialtybiologyChemistryRenal functionHydroxyethyl starchExcretionBasal (phylogenetics)EndocrinologyPharmacokineticsInternal medicinemedicinebiology.proteinAmylaseLipasemedicine.drug
researchProduct

Crystalloids and hydroxyethyl starches in noncardiac surgical patients

2016

Hydroxyethyl Starch Derivativesmedicine.medical_specialtybusiness.industryPlasma SubstitutesCrystalloid Solutions030204 cardiovascular system & hematologyPlasma SubstitutesSurgeryHydroxyethyl Starch Derivatives03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicine030202 anesthesiologyHumansMedicineIsotonic SolutionsIsotonic SolutionsbusinessSurgical patientsEuropean Journal of Anaesthesiology
researchProduct

Small volume resuscitation with tempol is detrimental during uncontrolled hemorrhagic shock in rats.

2005

In a previous study, titration of a hypertonic saline (HTS) solution during severe uncontrolled hemorrhagic shock (UHS) failed to reduce mortality. In a separate study, a novel antioxidant, polynitroxylated albumin (PNA) plus tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), infused during shock increased long-term survival. We hypothesized that combining potent antioxidants with a hypertonic solution during UHS would preserve the logistical advantage of small volume resuscitation and improve survival.An UHS outcome model in rats was used. UHS phase I (90 min) included blood withdrawal of 30 ml/kg over 15 min, followed by tail amputation for uncontrolled bleeding. At 20 min, rats wer…

MaleMean arterial pressureResuscitationResuscitationEmergency NursingHydroxyethyl starchShock HemorrhagicAntioxidantsCyclic N-OxidesRats Sprague-DawleyIntensive careAlbuminsMedicineAnimalsSaline Solution Hypertonicbusiness.industryAlbuminDrug SynergismHypertonic salineRatsSurvival RateDisease Models AnimalHematocritHemostasisShock (circulatory)AnesthesiaEmergency MedicineFluid TherapySpin Labelsmedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugResuscitation
researchProduct

Titrated hypertonic/hyperoncotic solution for hypotensive fluid resuscitation during uncontrolled hemorrhagic shock in rats.

2002

In volume- or pressure-controlled hemorrhagic shock (HS) a bolus intravenous infusion of hypertonic/hyperoncotic solution (HHS) proved beneficial compared to isotonic crystalloid solutions. During uncontrolled HS in animals, however, HHS by bolus increased blood pressure unpredictably, and increased blood loss and mortality. We hypothesized that a titrated i.v. infusion of HHS, compared to titrated lactated Ringer's solution (LR), for hypotensive fluid resuscitation during uncontrolled HS reduces fluid requirement, does not increase blood loss, and improves survival.We used our three-phased uncontrolled HS outcome model in rats. HS phase I began with blood withdrawal of 3 ml/100g over 15 mi…

MaleMean arterial pressureResuscitationRinger's LactateResuscitationBlood PressureHemorrhageEmergency NursingHydroxyethyl starchShock HemorrhagicRats Sprague-DawleyBolus (medicine)Intensive careMedicineAnimalsInfusions IntravenousSaline Solution Hypertonicbusiness.industryOsmolar ConcentrationTitrimetrySurvival AnalysisRatsDisease Models AnimalBlood pressureTreatment OutcomeHemostasisAnesthesiaEmergency MedicineTonicityFluid TherapyHypotensionIsotonic SolutionsCardiology and Cardiovascular MedicinebusinessBlood Chemical Analysismedicine.drugResuscitation
researchProduct

Effects of a single-dose hypertonic saline hydroxyethyl starch on cerebral blood flow, long-term outcome, neurogenesis, and neuronal survival after c…

2012

The beneficial effects of hypertonic saline on neuronal survival and on cerebral blood flow have been shown in several animal models of global and focal brain ischemia. Because of the potential benefits of hypertonic solutions, it is hypothesized that hydroxyethyl starch enhances cerebral blood flow and improves long-term outcome after cardiac arrest and cardiopulmonary resuscitation in an animal model.Laboratory animal study.University animal research laboratory.Fifty-nine male Sprague-Dawley rats.Rats were randomized to receive either 7.2% saline/6% hypertonic saline hydroxyethyl starch (4 mL/kg) or vehicle (NaCl 0.9 %) after 9 mins of asphyxic cardiac arrest and cardiopulmonary resuscita…

MaleNeurogenesismedicine.medical_treatmentPlasma Substitutesmacromolecular substancesHydroxyethyl starchCritical Care and Intensive Care MedicineHydroxyethyl Starch DerivativesRats Sprague-DawleyBrain ischemiaRandom AllocationAnimalsMedicineCardiopulmonary resuscitationBeneficial effectsNeuronsbusiness.industryNeurogenesisBrainmedicine.diseaseCardiopulmonary ResuscitationRatsHypertonic salineBromodeoxyuridineCerebral blood flowCerebrovascular CirculationAnesthesiaHeart Arrest InducedTonicitybusinessmedicine.drugCritical Care Medicine
researchProduct